Azetidinyl oxadiazoles as potent mGluR5 positive allosteric modulators. 2012

Mathivanan Packiarajan, and Christine G Mazza Ferreira, and Sang-Phyo Hong, and Andrew D White, and Gamini Chandrasena, and Xiaosui Pu, and Robbin M Brodbeck, and Albert J Robichaud
Chemical & Pharmacokinetic Sciences, Lundbeck Research USA, Paramus, NJ 07652, USA. packiara@yahoo.com

A novel series of aryl azetidinyl oxadiazoles are identified as mGluR5 positive allosteric modulators (PAMs) with improved physico-chemical properties. N-substituted cyclohexyl and exo-norbornyl carboxamides, and carbamate analogs of azetidines are moderate to potent mGluR5 PAMs. The aryl, lower alkyl carboxamides analogs and sulfonamide analogs of azetidines are moderate mGluR5 negative allosteric modulators (NAMs). In the aryl oxadiazole moiety, substituents such as fluoro, chloro and methyl are well tolerated at the meta position while para substituents led to either inactive compounds or NAMs. A tight pharmacophore and subtle 'PAM to NAM switching' with close analogs makes the optimization of the series extremely challenging.

UI MeSH Term Description Entries
D010069 Oxadiazoles Compounds containing five-membered heteroaromatic rings containing two carbons, two nitrogens, and one oxygen atom which exist in various regioisomeric forms. Oxadiazole
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000494 Allosteric Regulation The modification of the reactivity of ENZYMES by the binding of effectors to sites (ALLOSTERIC SITES) on the enzymes other than the substrate BINDING SITES. Regulation, Allosteric,Allosteric Regulations,Regulations, Allosteric
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001384 Azetidines
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D018094 Receptors, Metabotropic Glutamate Cell surface proteins that bind glutamate and act through G-proteins to influence second messenger systems. Several types of metabotropic glutamate receptors have been cloned. They differ in pharmacology, distribution, and mechanisms of action. Glutamate Receptors, Metabotropic,Metabotropic Glutamate Receptors,Receptors, Glutamate, Metabotropic,Metabotropic Glutamate Receptor,Glutamate Receptor, Metabotropic,Receptor, Metabotropic Glutamate
D064529 Receptor, Metabotropic Glutamate 5 A type I G protein-coupled receptor mostly expressed post-synaptic pyramidal cells of the cortex and CENTRAL NERVOUS SYSTEM. Metabotropic Glutamate Receptor 5,Receptor 5, Metabotropic Glutamate,Metabotropic Glutamate Receptor 5a,Metabotropic Glutamate Receptor 5b,mGluR5 Protein,mGluR5a Protein,mGluR5b Protein,Protein, mGluR5,Protein, mGluR5a,Protein, mGluR5b

Related Publications

Mathivanan Packiarajan, and Christine G Mazza Ferreira, and Sang-Phyo Hong, and Andrew D White, and Gamini Chandrasena, and Xiaosui Pu, and Robbin M Brodbeck, and Albert J Robichaud
June 2011, Bioorganic & medicinal chemistry letters,
Mathivanan Packiarajan, and Christine G Mazza Ferreira, and Sang-Phyo Hong, and Andrew D White, and Gamini Chandrasena, and Xiaosui Pu, and Robbin M Brodbeck, and Albert J Robichaud
December 2016, Bioorganic & medicinal chemistry letters,
Mathivanan Packiarajan, and Christine G Mazza Ferreira, and Sang-Phyo Hong, and Andrew D White, and Gamini Chandrasena, and Xiaosui Pu, and Robbin M Brodbeck, and Albert J Robichaud
December 2010, Bioorganic & medicinal chemistry letters,
Mathivanan Packiarajan, and Christine G Mazza Ferreira, and Sang-Phyo Hong, and Andrew D White, and Gamini Chandrasena, and Xiaosui Pu, and Robbin M Brodbeck, and Albert J Robichaud
October 2010, Bioorganic & medicinal chemistry letters,
Mathivanan Packiarajan, and Christine G Mazza Ferreira, and Sang-Phyo Hong, and Andrew D White, and Gamini Chandrasena, and Xiaosui Pu, and Robbin M Brodbeck, and Albert J Robichaud
July 2013, Bioorganic & medicinal chemistry letters,
Mathivanan Packiarajan, and Christine G Mazza Ferreira, and Sang-Phyo Hong, and Andrew D White, and Gamini Chandrasena, and Xiaosui Pu, and Robbin M Brodbeck, and Albert J Robichaud
July 2011, Bioorganic & medicinal chemistry letters,
Mathivanan Packiarajan, and Christine G Mazza Ferreira, and Sang-Phyo Hong, and Andrew D White, and Gamini Chandrasena, and Xiaosui Pu, and Robbin M Brodbeck, and Albert J Robichaud
May 2019, ACS medicinal chemistry letters,
Mathivanan Packiarajan, and Christine G Mazza Ferreira, and Sang-Phyo Hong, and Andrew D White, and Gamini Chandrasena, and Xiaosui Pu, and Robbin M Brodbeck, and Albert J Robichaud
August 2015, Bioorganic & medicinal chemistry letters,
Mathivanan Packiarajan, and Christine G Mazza Ferreira, and Sang-Phyo Hong, and Andrew D White, and Gamini Chandrasena, and Xiaosui Pu, and Robbin M Brodbeck, and Albert J Robichaud
October 2011, Bioorganic & medicinal chemistry letters,
Mathivanan Packiarajan, and Christine G Mazza Ferreira, and Sang-Phyo Hong, and Andrew D White, and Gamini Chandrasena, and Xiaosui Pu, and Robbin M Brodbeck, and Albert J Robichaud
July 2011, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!